Goran Krilov

Title: Goran Krilov - Innovator in Pharmaceutical Compounds

Introduction

Goran Krilov is an accomplished inventor based in Long Island City, NY, known for his significant contributions to the field of pharmaceuticals. With a strong focus on developing innovative compounds for various medical applications, he holds three patents that highlight his expertise and commitment to improving healthcare.

Latest Patents

Goran’s latest patents include a compound having KDM5 inhibitory activity, which is disclosed as a compound useful as a prophylactic and/or therapeutic agent for serious conditions such as cancer, Huntington's disease, and Alzheimer's disease. His research demonstrates the potential for these compounds or their salts in tackling debilitating diseases. Additionally, he has developed anti-malarial agents related to new pyrrole derivatives aimed at preventing or treating malaria, showcasing his dedication to addressing global health challenges through innovative solutions.

Career Highlights

Throughout his career, Goran Krilov has collaborated with notable organizations such as Ono Pharmaceutical Co., Ltd. and the University of Texas System. His work with these institutions illustrates his commitment to advancing medical science and contributing toward the development of effective therapeutic agents.

Collaborations

In his professional journey, Goran has had the opportunity to work alongside esteemed colleagues such as Akito Kakuuchi and Shuhei Umemura. These collaborations have likely enriched his inventive process and contributed to the successful development of his patents.

Conclusion

Goran Krilov represents a remarkable figure in the realm of pharmaceutical innovation. His patents not only reflect his inventive spirit but also emphasize his dedication to discovering treatments that may enhance patient outcomes in critical health areas. As he continues to push the boundaries of medical science, his contributions are sure to benefit numerous lives.